Transcriptomics

Dataset Information

0

The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome


ABSTRACT: To gain insight into the signaling pathway(s) required for ABL1/ABL2-kinase activity or effected by Ponatinib treatment, we evaluated the consequences of single or double inactivation of ABL1/ABL2 cells, or Ponatinib treated cells on the transcriptome of breast cancer cells. To examine the consequences of depleting the ABL kinases, or Ponatinib treatment on the transcriptome of lung metastatic breast cancer cells we employed next generation sequencing (RNAseq) analysis. We found that 321 genes were significantly differently expressed in Ponatinib treated LM2 cells, and 73 genes were differently expressed in double inactivation of ABL1/ABL2 LM2 cells. However, only about 3.4 percent of Ponatinib affected genes can also be changed by ABL knocking down.

ORGANISM(S): Homo sapiens

PROVIDER: GSE95079 | GEO | 2018/03/01

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2016-03-02 | E-GEOD-69125 | biostudies-arrayexpress
2016-03-02 | GSE69125 | GEO
2018-03-16 | PXD007118 | Pride
2023-10-04 | GSE224691 | GEO
2023-02-20 | PXD037501 | Pride
2022-03-14 | PXD032188 | Pride
2020-02-12 | E-MTAB-8773 | biostudies-arrayexpress
2023-12-19 | GSE242036 | GEO
2023-01-30 | GSE190438 | GEO
2017-01-28 | GSE77422 | GEO